NCT02434133View on ClinicalTrials.gov

Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

December 31, 2017

Conditions
Inflammatory Bowel Disease (IBD)
Interventions
PROCEDURE

Blood Draw/Data Collection

Participation will involve an extra 8ml tube of blood and a review of their medical records for medications and immunization history.

Trial Locations (1)

53792

University of Wisconsin Hospital & Clinics, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT02434133 - Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients | Biotech Hunter | Biotech Hunter